4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000062
Director sold 2,750 shares at $17.29 ($47,548)
From the SEC's structured data for this filing
Trades in this filing
Krognes Steve E. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-13 | Sale : show line 1 in the form | −2,750 | $17.29 | $47,548 | 139,841 | D |
| Open-market sales · 2,750 sh · avg $17.29 · $47,548 | ||||||
Loading xslF345X05/wk-form4_1708049752.xml…